Responses
Epidemiology and outcomes
Original research
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.